Glenmark Life Sciences

Glenmark Life Sciences: Nirma’s open supply and key insights on the inventory

by

Within the strategy of Nirma’s takeover of Glenmark Life Sciences (GLS) from its promoters Glenmark Pharma (GLP), an open supply to public shareholders can be constituted of February 15 to 29. With GLS buying and selling at ₹866 on February 13, owing to a turnaround in business state of affairs, the open supply value of … Read more

CCI Approves Nirma’s Majority Stake Purchase in Glenmark Life Sciences

by

The Competitors Fee of India (CCI) has given its nod for acquisition of majority shareholding of Glenmark Life Sciences Restricted by Nirma Ltd.  “CCI approves acquisition of majority shareholding of the Glenmark Life Sciences Ltd by the Nirma Ltd”, mentioned a CCI put up in platform ‘X’, which was previously often called Twitter.  In September … Read more